Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Gynuity Health Projects615 enrolled

Overview

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

615

Conditions

Termination of Pregnancy

Interventions

MifepristoneDRUG

home administration of mifepristone

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Reproductive age women seeking abortion services. * Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken. * Participants must be eligible for medical abortion according to clinician and clinic standards. * In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.

Locations (7)

Feminist Women's Health Center

Atlanta, Georgia, United States

Institute for Family Health

New York, New York, United States

Family Health Center, Montefiore Medical Center

The Bronx, New York, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Proportion of women who select home-use of mifepristone

Time frame: 1-2 weeks

Satisfaction with Method

Time frame: 1-2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.